Tagworks' CEO Marc Robillard is one of the speakers at Antibody Engineering & Therapeutics Europe 2018 in Amsterdam from 5-7 June.

Marc will present the company's latest results on "Click chemistry-triggered drug release from a tumor-bound ADC" on Thursday 7 June. His lecture is part of a session on "Novel antibody-based therapeutics for cancer and immuno-oncology"

More information on the event: https://lifesciences.knect365.com/antibody-engineering-europe/speakers